CAR T-cell therapy, a groundbreaking form of immunotherapy for cancer treatment, is indeed available in Israel, reflecting the country's commitment to advanced medical treatments and research. Israel, known for its cutting-edge medical technology and research, has integrated CAR T-cell therapy into its healthcare system, particularly for the treatment of certain types of blood cancers like acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).
Israeli medical centers, such as the Sheba Medical Center and the Hadassah Medical Center, are among those offering this innovative therapy. They not only provide treatment but also engage in clinical trials and research to further refine and expand the applications of CAR T-cell therapy. This inclusion of CAR T-cell therapy in Israel's medical arsenal is part of a broader trend in the country towards embracing novel and highly effective treatments for complex diseases, underlining Israel's status as a hub for medical innovation and patient care in oncology and other fields.
Blood cancer patient? Find out if you are eligible for CAR-T therapy in Israel ->
